Suppression of transformed phenotypes of human fibrosarcoma cells by overexpression of recombinant fibronectin

Cancer Research

Volumn 56, Issue 19, 1996, Pages 4541-4546

  Akamatsu, Hiroki ^a,b   Ichihara Tanaka, Keiko ^a,c   Ozono, Keiichi ^a   Kamiike, Wataru ^b   Matsuda, Hikaru ^b   Sekiguchi, Kiyotoshi ^a  

^a RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; RECOMBINANT FIBRONECTIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CELL TRANSFORMATION; CONTROLLED STUDY; FIBROSARCOMA; GROWTH REGULATION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL ADHESION; CELL DIVISION; DNA, COMPLEMENTARY; FEMALE; FIBRONECTINS; FIBROSARCOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PHENOTYPE; RECEPTORS, FIBRONECTIN; RECOMBINANT FUSION PROTEINS; TRANSFECTION; TUMOR STEM CELL ASSAY;

EID: 0029783254     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Hynes, R. O Fibronectins. New York: Springer-Verlag, 1990.
2. Camemolla, B., Balza, E., Siri, A , Zardi, L , Nicotra, M. R , Bigotti, A , and Natali, P. G. A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. J. Cell Biol., 108: 1139-1148, 1989.
3. ffrench-Constant, C., and Hynes, R O. Alternative splicing of fibronectin is temporally and spatially regulated in the chicken embryo. Development, 106: 375-388, 1989.
4. ffrench-Constant, C , Van De Water, L , Dvorak, H. F , and Hynes, R. O. Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat J. Cell Biol., 109: 903-914, 1989
5. Oyama, F., Hirohashi, S., Shimosato, Y., Titani, K , and Sekiguchi, K. Deregulation of alternative splicing of fibronectin pre-mRNA in malignant human liver tumors. J. Biol. Chem, 264: 10331-10334, 1989
6. Jamagin, W. R. Rockey, D. C., Koteliansky, V. E., Wang, S.-S., and Bissell, D. M. Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J. Cell Biol., 127: 2037-2048, 1994.
7. Hynes, R. O. Alteration of cell-surface proteins by viral transformation and by proteolysis. Proc Natl Acad. Sci. USA, 70: 3170-3174, 1973.
8. Gahmberg, C. G., and Hakomori, S. Altered growth behavior of malignant cells associated with changes in externally labelled glycoprotein and glycolipid Proc Natl. Acad. Sci. USA, 70: 3329-3333, 1973.
9. Chen, L. B., Summerhayes, I., Hsieh, P., and Gallimore, P. H. Possible role of fibronectin in malignancy. J. Supramol. Struct., 12: 139-150, 1979.
10. Der, C J., and Stanbridge, E J. Alterations in the extracellular matrix organization associated with the reexpression of tumorigenicity in human cell hybrids Int J. Cancer, 26: 451-459, 1980
11. Hayman, E. G , Engvall, E., and Ruoslahti, E. Butyrate restores fibronectin at cell surface of transformed cells. Exp. Cell Res., 127: 478-481, 1980.
12. Nielson, S. E., and Puck, T. T Deposition of fibronectin in the course of reverse transformation of Chinese hamster ovary cells by cyclic AMP. Proc. Natl. Acad Sci. USA, 77: 985-989, 1980
13. Noda, M , Kitayama, H., Matsuzaki, T., Sugimoto, Y., Okayama, H., Bassin, R. H., and Tkawa, Y. Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes. Proc. Natl. Acad. Sci. USA, 86: 162-166, 1989.
14. Yamada, K. M., Yamada, S , and Pastan, I. Cell surface protein partially restores morphology, adhesiveness, and contact inhibition of movement to transformed fibroblasts. Proc. Natl. Acad. Sci. USA, 73: 1217-1221, 1976
15. Giancotti, F. G., and Ruoslahti, E. Elevated levels of the α5β1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell, 60: 849-859, 1990.
16. Juliano, R. L , and Haskill, S. Signal transduction from the extracellular matrix. J. Cell Biol., 120: 577-585, 1993.
17. Miyamoto, S , Teramoto, H , Coso, O A., Gutkind, J S , Burbelo, P. D., Akiyama, S K., and Yamada, K. M Integrin function: molecular hierarchies of cytoskeletal and signaling molecules J Cell Biol, 131: 791-805, 1995.
18. Symington, B. E Fibronectin receptor modulates cyclin-dependent kinase activity. J. Biol. Chem., 267: 25744-25747, 1992.
19. Zhang, Z , Vuori, K., Reed, J. C , and Ruoslahti, E The α5β1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc. Natl. Acad. Sci. USA, 92: 6161-6165, 1995.
20. Matsuyama, S , Ichihara-Tanaka, K , and Sekiguchi, K. Targeting of the immunoglobulin-binding domain of protein A to the extracellular matrix using a minifibronectin expression vector. J Biochem. (Tokyo), 116: 898-904, 1994.
21. Petersen, T E., Skorstengaard, K , and Vibe-Pedersen, K. Primary structure of fibronectin. In D F. Mosher (ed.), Fibronectin, pp. 1-24. San Diego: Academic Press, 1989.
22. Ichihara-Tanaka, K., Maeda, T., Titani, K., and Sekiguchi, K. Matrix assembly of recombinant fibronectin polypeptide consisting of amino-terminal 70 kDa and carboxyl-terminal 37 kDa regions. FEBS Lett., 299: 155-158, 1992
23. Ichihara-Tanaka, K., Titani, K., and Sekiguchi, K. Role of the carboxyl-terminal Fib2 domain in fibronectin matrix assembly. J Cell Sci., 108 907-915, 1995.
24. Kornblihtt, A. R., Vibe-Pedersen, K, and Baralle, F. E. Human fibronectin cell specific alternative mRNA splicing generates polypeptide chains differing in the number of internal repeats. Nucleic Acids Res., 12: 5853-5868, 1984.
25. Goodman, S. L., Vollmers, H. P., and Birchmeier, W Control of cell locomotion: perturbation with an antibody directed against specific glycoproteins. Cell, 41: 1029-1038, 1985.
26. Clark, E. A., and Brugge, J. Integrins and signal transduction pathways: the road taken. Science (Washington DC), 268: 233-239, 1995.
27. Meredith, J. E., Jr., Fazeli, B., and Schwartz, M. A. The extracellular matrix as a cell survival factor. Mol. Biol. Cell, 4 953-961, 1993.
28. Schreiner, C , Fisher, M , Hussein, S., and Juliano, R. L. Increased tumorigenicity of fibronectin receptor deficient Chinese hamster ovary cell variants. Cancer Res., 51: 1738-1740, 1991.
29. Varner, J. A., Emerson, D. A., and Juliano, R. L. Integrin α5β1 expression negatively regulates cell growth: reversal by attachment to fibronectin. Mol. Biol. Cell, 6: 725-740, 1995.
30. Steel, D M., and Harris, H. The effect of antisense RNA to fibronectin on the malignancy of hybrids between melanoma cells and normal fibroblasts. J. Cell Sci., 93: 515-524, 1989.
31. Del Sal, G., Ruaro, M. E , Philipson, L., and Schneider, C. The growth arrest-specific gene, gas-1, is involved in growth suppression. Cell, 70: 595-607, 1992.
32. Wang, D., Birkenmeier, T. M , Yang, J , Benkateswarlu, S., Humphrey, L., Brattain, M. G., and Sun, L Release from quiescence stimulates the expression of integrin α5β1 which regulates DNA synthesis in human fibrosarcoma HT1080 cells J. Cell. Physiol., 164: 499-508, 1995.
33. Sugahara, H., Kanakura, Y., Furitsu, T., Ishihara, K , Oritani, K., Ikeda, H., Kitayama, H., Ishikawa, J , Hashimoto, K , Kanayama, Y., and Matsuzawa, Y. Induction of programmed cell death in human hematopoietic cell lines by fibronectin via its interaction with very late antigen 5. J Exp. Med , 179: 1757-1766, 1994.
34. Oyama, F., Hirohashi, S , Sakamoto, M., Titani, K., and Sekiguchi, K. Coordinate oncodevelopmental modulation of alternative splicing of fibronectin pre-messenger RNA at ED-A, ED-B, and CS1 regions in human liver tumors Cancer Res., 53: 2005-2011, 1993.